The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Effect of Vitamin E and Memantine on Functional Decline in Alzheimer Disease: The TEAM-AD VA Cooperative Randomized Trial
Open accessAbstract
IMPORTANCE: Although vitamin E and memantine have been shown to have beneficial effects in moderately severe Alzheimer disease (AD), evidence is limited in mild to moderate AD. OBJECTIVE: To determine if vitamin E (alpha tocopherol), memantine, or both slow progression of mild to moderate AD in patients taking an acetylcholinesterase inhibitor. DESIGN, SETTING, AND PARTICIPANTS: Double-blind, placebo-controlled, parallel-group, randomized clinical trial involving 613 patients with mild to moderate AD initiated in August 2007 and concluded in September 2012 at 14 Veterans Affairs medical centers. INTERVENTIONS: Participants received either 2000 IU/d of alpha tocopherol (n = 152), 20 mg/d of memantine (n = 155), the combination (n = 154), or placebo (n = 152). MAIN OUTCOMES AND MEASURES: Alzheimer's Disease Cooperative Study/Activities of Daily Living (ADCS-ADL) Inventory score (range, 0-78). Secondary outcomes included cognitive, neuropsychiatric, functional, and caregiver measures. RESULTS: Data from 561 participants were analyzed (alpha tocopherol = 140, memantine = 142, combination = 139, placebo = 140), with 52 excluded because of a lack of any follow-up data. Over the mean (SD) follow-up of 2.27 (1.22) years, ADCS-ADL Inventory scores declined by 3.15 units (95% CI, 0.92 to 5.39; adjusted P = .03) less in the alpha tocopherol group compared with the placebo group. In the memantine group, these scores declined 1.98 units less (95% CI, -0.24 to 4.20; adjusted P = .40) than the placebo group's decline. This change in the alpha tocopherol group translates into a delay in clinical progression of 19% per year compared with placebo or a delay of approximately 6.2 months over the follow-up period. Caregiver time increased least in the alpha tocopherol group. All-cause mortality and safety analyses showed a difference only on the serious adverse event of "infections or infestations," with greater frequencies in the memantine (31 events in 23 participants) and combination groups (44 events in 31 participants) compared with placebo (13 events in 11 participants). CONCLUSIONS AND RELEVANCE: Among patients with mild to moderate AD, 2000 IU/d of alpha tocopherol compared with placebo resulted in slower functional decline. There were no significant differences in the groups receiving memantine alone or memantine plus alpha tocopherol. These findings suggest benefit of alpha tocopherol in mild to moderate AD by slowing functional decline and decreasing caregiver burden. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT00235716.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“high-dose vitamin E (1000 IU twice daily was the regimen tested) may be considered based on results of 2 RCTs that supported approximately 20% lower rate of ADL decline over approximately 2 to 3 years; there were no concerning safely signals or increased mortality with high-dose vitamin E. 127,128”
From The Alzheimer’s Disease Clinical Spectrum (2019) · cites this paper as [128]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987) · Journal of Chronic Diseases · doi:10.1016/0021-9681(87)90171-8 · Cited by 49,742
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
The Statistical Analysis of Failure Time Data.
Aitkin, M. A., Kalbfleisch, J. D., & Prentice, R. L. (1981) · Biometrics · doi:10.2307/2530581 · Cited by 9,875
The Neuropsychiatric Inventory: Comprehensive assessment of psychopathology in dementia
Cummings, J. L., Mega, M., Gray, K., Rosenberg-Thompson, S., Carusi, D. A., & Gornbein, J. (1994) · Neurology · doi:10.1212/wnl.44.12.2308 · Cited by 7,568
A sharper Bonferroni procedure for multiple tests of significance
HOCHBERG, Y. (1988) · Biometrika · doi:10.1093/biomet/75.4.800 · Cited by 4,829
A new rating scale for Alzheimer's disease
(1984) · American Journal of Psychiatry · doi:10.1176/ajp.141.11.1356 · Cited by 4,175
Meta-Analysis: High-Dosage Vitamin E Supplementation May Increase All-Cause Mortality
Miller, E. R., Pastor-Barriuso, R., Dalal, D., Riemersma, R. A., Appel, L. J., & Guallar, E. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-1-200501040-00110 · Cited by 2,577
A Controlled Trial of Selegiline, Alpha-Tocopherol, or Both as Treatment for Alzheimer's Disease
Sano, M., Ernesto, C., Thomas, R. G., Klauber, M. R., Schafer, K., Grundman, M., Woodbury, P., Growdon, J., Cotman, C. W., Pfeiffer, E., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704243361704 · Cited by 2,380
Self-citationMemantine in Moderate-to-Severe Alzheimer's Disease
Reisberg, B., Doody, R., Stöffler, A., Schmitt, F., Ferris, S., & Möbius, H. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa013128 · Cited by 2,043
Cited by
Sorted by citations
Items 201–300 of 630
New Possibilities in the Therapeutic Approach to Alzheimer’s Disease
Doroszkiewicz, J., & Mroczko, B. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23168902 · Cited by 46
Tsoi, K. K. F., Chan, J. Y. C., Leung, N. W. Y., Hirai, H. W., Wong, S. Y. S., & Kwok, T. C. Y. (2016) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2016.05.015 · Cited by 37
Vitamin E and Alzheimer’s Disease—Is It Time for Personalized Medicine?
Cervantes, B. R., & Ulatowski, L. M. (2017) · Antioxidants · doi:10.3390/antiox6030045 · Cited by 37
Nutrition: Review on the Possible Treatment for Alzheimer’s Disease
Botchway, B. O. A., Moore, M. K., Akinleye, F. O., Iyer, I. C., & Fang, M. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170874 · Cited by 38
Therapeutic Opportunities for Food Supplements in Neurodegenerative Disease and Depression
Businaro, R., Vauzour, D., Sarris, J. J., Münch, G. W., Gyengési, E., Brogelli, L., & Zuzarte, P. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.669846 · Cited by 42
The effects of twenty-one nutrients and phytonutrients on cognitive function: A narrative review
Lewis, J. E., Poles, J., Shaw, D. P., Karhu, E., Khan, S. A., Lyons, A. E., Sacco, S. B., & McDaniel, H. R. (2021) · Journal of Clinical and Translational Research · doi:10.18053/jctres.07.202104.014 · Cited by 37
Fernández, S. S. M., Ivanauskas, T. M., & Ribeiro, S. M. L. (2017) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2017.06.015 · Cited by 36
Enjoy Carefully: The Multifaceted Role of Vitamin E in Neuro-Nutrition
Regner-Nelke, L., Nelke, C., Schroeter, C. B., Dziewas, R., Warnecke, T., Ruck, T., & Meuth, S. G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221810087 · Cited by 36
Bioenergetics and metabolism: a bench to bedside perspective
Swerdlow, R. H. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13509 · Cited by 35
New Therapeutics to Modulate Mitochondrial Function in Neurodegenerative Disorders
Wilkins, H., & Morris, J. K. (2017) · Current Pharmaceutical Design · doi:10.2174/1381612822666161230144517 · Cited by 34
Galogahi, F. M., Hatamian-Zarmi, A., Ganji, F., Ebrahimi-Hosseinzadeh, B., Nojoki, F., Sahraeian, R., & Mokhtari‐Hosseini, Z. B. (2017) · Journal of Liposome Research · doi:10.1080/08982104.2017.1349143 · Cited by 35
Solfrizzi, V., Agosti, P., Lozupone, M., Custodero, C., Schilardi, A., Valiani, V., Santamato, A., Sardone, R., Dibello, V., Lena, L. D., et al. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.10.022 · Cited by 38
Role of nutraceuticals in cognition during aging and related disorders
Singh, P., Sivanandam, T. M., Konar, A., & Thakur, M. K. (2020) · Neurochemistry International · doi:10.1016/j.neuint.2020.104928 · Cited by 37
Zhang, N., Wei, C., Du, H.-J., Shi, F., & Cheng, Y. (2015) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000430808 · Cited by 35
Protective effect of vitamin E against acute kidney injury
Liu, P., Feng, Y., Wang, Y., Zhou, Y., & Zhao, L. (2015) · Bio-Medical Materials and Engineering · doi:10.3233/bme-151519 · Cited by 33
Tschiffely, A. E., Schuh, R. A., Prókai-Tátrai, K., Prókai, L., & Ottinger, M. A. (2016) · Hormones and Behavior · doi:10.1016/j.yhbeh.2016.05.009 · Cited by 34
The Latest Advances in the Diagnosis and Treatment of Dementia
Hafiz, R., Alajlani, L., Ali, A., Algarni, G. A., Aljurfi, H., Alammar, O. A. M., Ashqan, M. Y., & Alkhashan, A. Y. (2023) · Cureus · doi:10.7759/cureus.50522 · Cited by 41
Khan, G., Hussain, M. S., Khan, Y., Fatima, R., Ahmad, S., Sultana, A., & Alam, P. (2025) · Brain Research · doi:10.1016/j.brainres.2025.149776 · Cited by 35
Effect of vitamin E on 24(S)-hydroxycholesterol-induced necroptosis-like cell death and apoptosis
Nakazawa, T., Miyanoki, Y., Urano, Y., Uehara, M., Saito, Y., & Noguchi, N. (2016) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.03.003 · Cited by 33
Prasansuklab, A., & Tencomnao, T. (2018) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-018-2340-4 · Cited by 33
Šagud, M., Tudor, L., & Pivac, N. (2021) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2021.1906223 · Cited by 31
Chen, Y.-Y., Wang, M.-C., Wang, Y.-N., Hu, H.-H., Liu, Q.-Q., Liu, H.-J., & Zhao, Y.-Y. (2020) · Biomarker Research · doi:10.1186/s40364-020-00218-z · Cited by 33
Ding, H., Reiss, A. B., Pinkhasov, A., & Kasselman, L. J. (2022) · Medicina · doi:10.3390/medicina58081025 · Cited by 32
Bharate, J. B., Wani, A., Sharma, S., Reja, S. I., Kumar, M., Vishwakarma, R. A., Kumar, A., & Bharate, S. B. (2014) · Organic & Biomolecular Chemistry · doi:10.1039/c4ob00488d · Cited by 32
Effects of garden visits on people with dementia: A pilot study
Liao, M.-L., Ou, S.-J., Hsieh, C.-H., Li, Z., & Ko, C.-C. (2018) · Dementia · doi:10.1177/1471301218793319 · Cited by 33
Nutritional supplementation for Alzheimerʼs disease?
Shea, T. B., & Remington, R. (2015) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000138 · Cited by 32
A Review of Recent Advances in the Management of Alzheimer’s Disease
Skylynn, T., Lee, C. S., Metchikoff, E., Razdan, V., Suliman, G., Rivera, D., Pinto, A., & Pemminati, S. (2024) · Cureus · doi:10.7759/cureus.58416 · Cited by 37
Recent Insights into the Neurobiology of Alzheimer’s Disease and Advanced Treatment Strategies
Anitha, K., Singh, M. K., Kohat, K., Varshini, T. S., Chenchula, S., Padmavathi, R., Amerneni, L. S., Vishnu Vardhan, K., Mythili Bai, K., Chavan, M. R., et al. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04384-1 · Cited by 35
Černelič-Bizjak, M., Pražnikar, Z. J., Kenig, S., Hladnik, M., Bandelj, D., Gregori, A., & Kranjc, K. (2024) · Journal of Functional Foods · doi:10.1016/j.jff.2024.106120 · Cited by 35
Dietary Interventions to Prevent or Delay Alzheimer’s Disease: What the Evidence Shows
Bartochowski, Z., Conway, J., Wallach, Y., Chakkamparambil, B., Alakkassery, S., & Grossberg, G. T. (2020) · Current Nutrition Reports · doi:10.1007/s13668-020-00333-1 · Cited by 31
Fragile X premutation and associated health conditions: A review
Tassanakijpanich, N., Hagerman, R. J., & Worachotekamjorn, J. (2021) · Clinical Genetics · doi:10.1111/cge.13924 · Cited by 30
Jain, S., Singh, R., Paliwal, S., & Sharma, S. K. (2023) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557523666230511122435 · Cited by 35
Oxidative Stress in Alzheimer’s Disease: The Shortcomings of Antioxidant Therapies
Pappolla, M. A., Martins, R. N., Poeggeler, B., Omar, R. A., & Perry, G. (2024) · Journal of Alzheimer's Disease · doi:10.3233/jad-240659 · Cited by 29
Botchway, B. O., Okoye, F. C., Chen, Y., Arthur, W. E., & Fang, M. (2022) · Aging and disease · doi:10.14336/ad.2021.0616 · Cited by 32
Matsunaga, S., Kishi, T., & Iwata, N. (2014) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2014.05.1710 · Cited by 29
Rockwood, K. J., Howlett, S. E., Hoffman, D., Schindler, R. J., & Mitnitski, A. (2017) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2017.02.005 · Cited by 29
Durani, L. W., Hamezah, H. S., Ibrahim, N. F., Yanagisawa, D., Nasaruddin, M. L., Mori, M., Azizan, K. A., Damanhuri, H. A., Makpol, S., Ngah, W. Z. W., et al. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170880 · Cited by 31
Rommer, P. S., Fuchs, D., Leblhuber, F., Schroth, R., Greilberger, M., Tafeit, E., & Greilberger, J. (2015) · Neurodegenerative Diseases · doi:10.1159/000441565 · Cited by 29
Tsoi, K. K. F., Chan, J. Y. C., Chan, F. C. H., Hirai, H. W., Kwok, T. C. Y., & Wong, S. Y. S. (2018) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1104 · Cited by 30
Healthy brain ageing and cognition: Nutritional factors
Vandewoude, M. F. J., Barberger‐Gateau, P., Cederholm, T., Mecocci, P., Salvà, A., Sergi, G., Topinková, E., & van Asselt, D. (2016) · European Geriatric Medicine · doi:10.1016/j.eurger.2015.12.005 · Cited by 31
N-of-1 Clinical Trials in Nutritional Interventions Directed at Improving Cognitive Function
Soldevila‐Domenech, N., Boronat, A., Langohr, K., & de la Torre, R. (2019) · Frontiers in Nutrition · doi:10.3389/fnut.2019.00110 · Cited by 27
Sayed, A. E. H., Abd-Allah, E. A., Hamed, M., & Soliman, H. A. M. (2020) · Pesticide Biochemistry and Physiology · doi:10.1016/j.pestbp.2020.104600 · Cited by 28
Role of Mitochondrial Dysfunction in the Pathology of Amyloid-β
Huang, Z., Yan, Q., Wang, Y., Zou, Q., Li, J., Liu, Z., & Cai, Z. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200519 · Cited by 28
Association Between Serum Vitamins and the Risk of Alzheimer’s Disease in Chinese Population
Liu, X., Wu, P.-F., Liu, Y., Jiang, Y., Wan, M., Xiao, X., Yang, Q., Jiao, B., Liao, X., Wang, J., et al. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-215104 · Cited by 28
Outcome Measures for Parkinson's Disease Dementia: A Systematic Review
Holden, S. K., Jones, W. E., Baker, K. A., Boersma, I. M., & Kluger, B. M. (2015) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.12225 · Cited by 29
Shen, R., Ardianto, C., Celia, C., Sidharta, V. M., Sasmita, P. K., Satriotomo, I., & Turana, Y. (2023) · Dementia & Neuropsychologia · doi:10.1590/1980-5764-dn-2023-0012 · Cited by 31
Alzheimer’s Disease: From Molecular Mechanisms to Promising Therapeutic Strategies
Ivanova, A. V., Kutuzova, A. D., Kuzmichev, I., & Abakumov, M. A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26199444 · Cited by 33
Clinical outcome measures in dementia with Lewy bodies trials: critique and recommendations
Rodriguez‐Porcel, F. E., Wyman‐Chick, K. A., Abdelnour, C., Toledo, J. B., Ferreira, D., Urwyler, P., Weil, R. S., Kane, J. P. M., Pilotto, A., Rongve, A., et al. (2022) · Translational Neurodegeneration · doi:10.1186/s40035-022-00299-w · Cited by 28
Diet, nutrients and metabolism: cogs in the wheel driving Alzheimer's disease pathology?
Creegan, R., Hunt, W., McManus, A., & Rainey‐Smith, S. R. (2015) · British Journal Of Nutrition · doi:10.1017/s0007114515000926 · Cited by 29
Alzheimer's disease: the role of mitochondrial dysfunction and potential new therapies
Hawking, Z. L. (2016) · Bioscience Horizons The International Journal of Student Research · doi:10.1093/biohorizons/hzw014 · Cited by 29
Cordero, K., Coronel, G., Serrano‐Illán, M., Cruz-Bracero, J., Figueroa, J. D., & León, M. A. D. (2018) · Brain Sciences · doi:10.3390/brainsci8030038 · Cited by 26
Cholinesterase inhibitors and add-on nutritional supplements in Alzheimer's disease
Rijpma, A., Meulenbroek, O., & Olde Rikkert, M. G. M. (2014) · Ageing Research Reviews · doi:10.1016/j.arr.2014.06.002 · Cited by 26
The effect of anti-dementia drugs on Alzheimer disease-induced cognitive impairment
Cui, C., Sun, Y., Wang, X., Zhang, Y., & Xing, Y. (2019) · Medicine · doi:10.1097/md.0000000000016091 · Cited by 26
Antioxidant Modulation of mTOR and Sirtuin Pathways in Age-Related Neurodegenerative Diseases
Abdullah, A., Murshid, N. M., & Makpol, S. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02083-1 · Cited by 29
Rondanelli, M., Faliva, M. A., Peroni, G., Moncaglieri, F., Infantino, V., Naso, M., & Perna, S. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161023227 · Cited by 25
Zhuo, Y., Guo, H., Cheng, Y., Wang, C., Wang, C., Wu, J., Zou, Z., Gan, D., Li, Y., & Xu, J. (2016) · Metabolic Brain Disease · doi:10.1007/s11011-016-9814-1 · Cited by 25
Monoclonal antibodies and aptamers: The future therapeutics for Alzheimer's disease
Barrera-Ocampo, A. A. (2024) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2024.03.034 · Cited by 30
Power, R., Nolan, J. M., Prado‐Cabrero, A., Coen, R. F., Roche, W., Power, T., Howard, A. N., & Mulcahy, R. (2020) · Journal of Personalized Medicine · doi:10.3390/jpm10020043 · Cited by 26
Vitamin E Supplementation Delays Cellular SenescenceIn Vitro
Fata, G. L., Seifert, N., Weber, P., & Mohajeri, M. H. (2015) · BioMed Research International · doi:10.1155/2015/563247 · Cited by 25
Cammisuli, D. M., Franzoni, F., Scarfò, G., Fusi, J., Gesi, M., Bonuccelli, U., Daniele, S., Martini, C., & Castelnuovo, G. (2022) · Biology · doi:10.3390/biology11050650 · Cited by 27
Catecholamine-Based Treatment in AD Patients: Expectations and Delusions
Stefani, A., Olivola, E., Liguori, C., Hainsworth, A. H., Saviozzi, V., Angileri, G., D’Angelo, V., Galati, S., & Pierantozzi, M. (2015) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2015.00067 · Cited by 24
Pharmacological interventions for cognitive decline in people with Down syndrome
Livingstone, N., Hanratty, J., Macdonald, G., & McShane, R. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011546 · Cited by 24
Zakharova, I. O., Bayunova, L. V., Zorina, I. I., Соколова, Т. В., Shpakov, A. O., & Avrova, N. F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111768 · Cited by 23
Site-specific mitochondrial dysfunction in neurodegeneration
Vodičková, A., Koren, S. A., & Wojtovich, A. P. (2022) · Mitochondrion · doi:10.1016/j.mito.2022.02.004 · Cited by 22
Picca, A., Ferri, E., Calvani, R., Coelho‐Júnior, H. J., Marzetti, E., & Arosio, B. (2022) · Nutrients · doi:10.3390/nu14122406 · Cited by 24
Chen, Z., Yu, L., Li, W., Zhang, H., Huang, X., Chen, W., & Wang, D. (2023) · Environmental Science and Pollution Research · doi:10.1007/s11356-023-26164-5 · Cited by 24
Lu, J., Guo, P., Liu, X., Zhang, Y., Guo, X., Gao, X. Y., & Chen, Y. (2019) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2019/8302950 · Cited by 23
Youn, H., & Jeong, H. (2018) · Journal of Korean Medical Association · doi:10.5124/jkma.2018.61.12.758 · Cited by 23
Hirata, Y., Tsunekawa, Y., Takahashi, M., Oh‐hashi, K., Kawaguchi, K., Hayazaki, M., Watanabe, M., Koga, K.-I., Hattori, Y., Takemori, H., et al. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.08.015 · Cited by 22
Therapeutic approaches of nutraceuticals in the prevention of Alzheimer's disease
Pandey, S. N., Singh, G., Semwal, B. C., Gupta, G., Alharbi, K. S., Almalki, W. H., Albratty, M., Najmi, A., & Meraya, A. M. (2022) · Journal of Food Biochemistry · doi:10.1111/jfbc.14426 · Cited by 23
Tong, J., Satyanarayanan, S. K., & Su, H. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.08.027 · Cited by 24
Moreira, S. C., Jansen, A. K., & Silva, F. M. (2020) · Dementia & Neuropsychologia · doi:10.1590/1980-57642020dn14-030008 · Cited by 23
New opportunities for antioxidants in amelioration of neurodegenerative diseases
Bhandari, U. R., Danish, S. M., Ahmad, S., Ikram, M., Nadaf, A., Hasan, N., Kesharwani, P., & Ahmad, F. J. (2024) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2024.111961 · Cited by 24
Ferroptosis and cognitive impairment: Unraveling the link and potential therapeutic targets
Naderi, S., Khodagholi, F., Janahmadi, M., Motamedi, F., Torabi, A., Batool, Z., Heydarabadi, M. F., & Pourbadie, H. G. (2024) · Neuropharmacology · doi:10.1016/j.neuropharm.2024.110210 · Cited by 23
100 Years of Vitamin E: From Discovery to Commercialization
Müller, M., Schäfer, C., Litta, G., Kluenter, A., Traber, M. G., Wyss, A., Ralla, T., Eggersdorfer, M. L., & Bonrath, W. (2022) · European Journal of Organic Chemistry · doi:10.1002/ejoc.202201190 · Cited by 21
Redox Imbalance in Neurological Disorders in Adults and Children
Rey, F., Berardo, C., Maghraby, E., Mauri, A., Messa, L., Esposito, L., Casili, G., Ottolenghi, S., Bonaventura, E., Cuzzocrea, S., et al. (2023) · Antioxidants · doi:10.3390/antiox12040965 · Cited by 23
Let Food Be Thy Medicine: Diet, Nutrition, and Biomarkers’ Risk of Alzheimer’s Disease
Mosconi, L., & McHugh, P. F. (2015) · Current Nutrition Reports · doi:10.1007/s13668-014-0111-5 · Cited by 22
Ying, M., Sui, X., Zhang, Y., Sun, Q., Qu, Z., Luo, X., Chang, R. C., Ni, J., Liu, J., & Yang, X. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9959-2 · Cited by 21
Perspectives on the Tertiary Prevention Strategy for Alzheimer's Disease
Bu, X., Jiao, S., Lian, Y., & Wang, Y. (2015) · Current Alzheimer Research · doi:10.2174/1567205013666151215110114 · Cited by 20
Souvenaid for Alzheimer's disease
Burckhardt, M., Watzke, S., Wienke, A., Langer, G., & Fink, A. M. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011679.pub2 · Cited by 19
Shiue, Y., Tseng, P., Zeng, B., Chen, Y., Yang, C., Su, K., Chen, T., Wu, Y., Tu, Y., Lin, P., et al. (2022) · Current Neuropharmacology · doi:10.2174/1570159x20666220420122322 · Cited by 21
Wang, G., Liu, L., Li, Y., Aschenbrenner, A. J., Bateman, R. J., Delmar, P., Schneider, L. S. S., Kennedy, R., Cutter, G., & Xiong, C. (2022) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.12286 · Cited by 20
Pontrello, C. G., McWhirt, J., Glabe, C. G., & Brewer, G. J. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220824 · Cited by 20
Melatonin in Alzheimer’s Disease: Literature Review and Therapeutic Trials
Steinbach, M. J., & Denburg, N. L. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-230760 · Cited by 21
Combination benefit of cognitive rehabilitation plus donepezil for A lzheimer's disease patients
Matsuzono, K., Hishikawa, N., Takao, Y., Wakutani, Y., Yamashita, T., Deguchi, K., & Abe, K. (2015) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.12455 · Cited by 20
Grimm, S., Gärtner, M., Fuge, P., Fan, Y., Weigand, A., Feeser, M., Aust, S., Heekeren, H. R., Jacobs, A. M., Heuser, I., et al. (2014) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2014.12.001 · Cited by 23
Wang, W., Li, J., Zhang, H., Wang, X., & Zhang, X. (2019) · Nutritional Neuroscience · doi:10.1080/1028415x.2019.1585506 · Cited by 20
Diet Associated with Inflammation and Alzheimer’s Disease
Vasefi, M., Hudson, M., & Ghaboolian-Zare, E. (2019) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-190152 · Cited by 21
The Role of Dietary Antioxidants and Their Potential Mechanisms in Alzheimer’s Disease Treatment
Knight, E., Geetha, T., Broderick, T. L., & Babu, J. R. (2023) · Metabolites · doi:10.3390/metabo13030438 · Cited by 20
Neuronutrition: An Emerging Concept
Topçuoğlu, M. A., & Arsava, E. M. (2017) · Springer eBooks · doi:10.1007/978-3-319-53171-7_10 · Cited by 19
Liang, J., Li, J., Jia, R., Wang, Y., Wu, R.-K., Zhang, H., Hang, L., & Xu, Y. (2018) · Clinical Interventions in Aging · doi:10.2147/cia.s184968 · Cited by 19
Plasma antioxidants and risk of dementia in older adults
Koch, M., Furtado, J. D., Cronjé, H. T., DeKosky, S. T., Fitzpatrick, A. L., López, O. L., Kuller, L. H., Mukamal, K. J., & Jensen, M. K. (2021) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.12208 · Cited by 19
Wang, J., Yu, Z., Ye, P., & Xu, B. (2023) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2023.109397 · Cited by 18
Bioinorganic Chemistry of Micronutrients Related to Alzheimer’s and Parkinson’s Diseases
Kola, A., Nencioni, F., & Valensin, D. (2023) · Molecules · doi:10.3390/molecules28145467 · Cited by 18
Neukirch, K., Alsabil, K., Dinh, C. P., Bilancia, R., Raasch, M., Ville, A., Cerqua, I., Viault, G., Bréard, D., Pace, S., et al. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c00806 · Cited by 18
Vitamins: a nutritional intervention to modulate the Alzheimer’s disease progression
Alam, J. (2020) · Nutritional Neuroscience · doi:10.1080/1028415x.2020.1826762 · Cited by 18
Cowan, C. M., Sealey, M. A., & Mudher, A. K. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.15253 · Cited by 17
Pharmacological intervention in oxidative stress as a therapeutic target in neurological disorders
Sharma, S., Advani, D., Das, A., Malhotra, N., Khosla, A., Arora, V., Jha, A., Yadav, M., Ambasta, R. K., & Kumar, P. (2021) · Journal of Pharmacy and Pharmacology · doi:10.1093/jpp/rgab064 · Cited by 19
Kocatürk, R. R., Temizyürek, A., Özcan, Ö. Ö., Erguzel, T. T., Karahan, M., Konuk, M., & Tarhan, N. (2022) · International Journal of Neuroscience · doi:10.1080/00207454.2022.2079506 · Cited by 17
An overview of structure-based activity outcomes of pyran derivatives against Alzheimer’s disease
Almalki, F. A. (2023) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2023.04.030 · Cited by 17
Metadata
- Authors
- Dysken, M. W., Sano, M., Asthana, S., Vertrees, J. E., Pallaki, M., Llorente, M., Love, S., Schellenberg, G. D., McCarten, J. R., Malphurs, J., Prieto, S., Chen, P., Loreck, D. J., Trapp, G., Bakshi, R. S., Mintzer, J. E., Heidebrink, J. L., Vidal-Cardona, A., Arroyo, L. M., Cruz, A. R., Zachariah, S., Kowall, N. W., Chopra, M. P., Craft, S., Thielke, S., Turvey, C. L., Woodman, C., Monnell, K. A., Gordon, K., Tomaska, J., Segal, Y., Peduzzi, P. N., & Guarino, P. D.
- Affiliations
- Minneapolis VA Health Care System (US)
- James J. Peters VA Medical Center (US)
- William S. Middleton Memorial Veterans Hospital (US)
- Cooperative Studies Program Clinical Research Pharmacy Coordinating Center, Albuquerque, New Mexico
- Louis Stokes Cleveland VA Medical Center (US)
- Washington DC VA Medical Center (US)
- University of Pennsylvania (US)
- Miami VA Healthcare System (US)
- VA Maryland Health Care System (US)
- VA North Texas Health Care System (US)
- Medical University of South Carolina (US)
- VA Ann Arbor Healthcare System (US)
- VA Caribbean Healthcare System, San Juan, Puerto Rico
- VA Caribbean Healthcare System (PR)
- Bay Pines VA Healthcare System (US)
- VA Boston Healthcare System (US)
- University of Washington (US)
- University of Iowa (US)
- W. G. (Bill) Hefner VA Medical Center (US)
- Yale University (US)
- ORCID
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2014-01-01
- Volume
- 311
- Issue
- 1
- Pages
- 33
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- PMC
- PMC4109898
- OpenAlex
- W2128047032
- Cited by
- 628
- References
- 40
- Citations by year
- 2026: 34 · 2025: 41 · 2024: 36 · 2023: 54 · 2022: 56 · 2021: 53 · 2020: 47 · 2019: 47 · 2018: 61 · 2017: 48 · 2016: 50 · 2015: 55 · 2014: 44
- FWCI
- 35.66
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- JAMA (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute on Aging (P50AG005138, P30AG013846, P50AG005136)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Pharmacology (medical) › Cholinesterase and Neurodegenerative Diseases
- Keywords
- Alzheimer's disease, vitamin E, alpha-tocopherol, memantine, functional decline, activities of daily living, acetylcholinesterase inhibitors, disease progression, caregiver burden, neuropsychiatric symptoms, adverse events, infections and infestations, combination therapy, veterans, older adults, cognitive decline, mortality, quality of life, cost-effectiveness
- MeSH terms
- Activities of Daily Living, Aged, Aged, 80 and over, Alzheimer Disease, Antioxidants, Cholinesterase Inhibitors, Double-Blind Method, Drug Therapy, Combination, Female, Humans, Male, Memantine, Middle Aged, Severity of Illness Index, Vitamin E, Dopamine Agents, Treatment Outcome, Caregivers, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
